Aggregator
CXCR4-targeted dual softener for inducing senescence therapy in hepatic fibrosis
Hepatic fibrosis is a central pathological driver of chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease and alcohol-related liver disease, which collectively impose a growing global health burden. Fibrosis is primarily mediated by persistent activation of hepatic stellate cells (aHSCs) and excessive deposition of stiff extracellular matrix (ECM). The dense and rigid ECM-aHSCs network severely hinders drug delivery and penetration, posing a major challenge...
Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy
Cell therapies represent a promising frontier in modern medicine. Mesenchymal stromal cells (MSCs) constitute a valuable source due to their minimal ethical concerns, low immunogenicity, negligible tumorigenicity in vivo, and robust paracrine activity mediated by the secretion of anti-inflammatory and angiogenic factors. Despite these advantages, MSCs undergo rapid replicative senescence accompanied by a progressive loss of stemness markers and functional potency. In this context, cellular...
Financial Decision-Making, Financial Literacy, and Cognitive Function: Evidence From the PATH Through Life Study
CONCLUSIONS: Better cognitive function was associated with higher objective financial literacy, whereas subjective financial literacy showed no association with cognitive performance. These findings highlight the importance of cognitive function for financial literacy in later midlife to early older age adults.
TRF2 Recovers Ischemic Postconditioning Cardioprotection in Aged Myocardiocytes by Regulating CSNK2A2 Localization and FUNDC1 Dephosphorylation
Ischemic postconditioning (I/Post), which is an effective intervention by activating endogenous cardioprotective pathways, recovers ischemia/reperfusion injury. However, this intervention is not as effective in older patients, and its mechanism needs to be further investigated. In this study, we found that myocardial telomeric repeat binding factor 2 (TRF2) protein expression in male aged mice (18 months of age) was lower than that in male adult mice (4 months of age). After ligation of the...
An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline
Adipose tissue senescence is increasingly recognized as a key driver of systemic aging and age-related functional decline, yet the endocrine regulators that actively promote this process remain poorly defined. Angiopoietin-like protein 8 (ANGPTL8) is a metabolic factor implicated in lipid metabolism and inflammation and has been associated with multiple aging-related disorders. However, its direct role in adipose tissue senescence and organismal aging remains unclear. Here, we identify ANGPTL8...
Daily briefing: Narcolepsy drug could kick off an Ozempic-style moment for the brain
First-of-its-kind narcolepsy drug opens door to new therapies for the brain
Why AI systems are most useful as designers of new scientific tools
Too hot to sleep? How heatwaves at night affect our health
Defect passivation and optical management of triple-junction solar cells
Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
Programmable remodelling of carbon–nitrogen connectivity in amines
Positional isomerisation of pyridine via nitrogen transposition
Universities must stop protecting bullies — or more people will leave science
How the story of life and our planet unfolded — together
NIH plan to keep peer-review scores for grants secret draws concern
Under “binning” proposal, applications’ numerical ratings would no longer be used for final funding decisions
Justice Department calls three NSF diversity programs unconstitutional
New ruling bars programs said to discriminate by race and sex, six others can continue if modified
Massive new animal disease lab in Kansas runs into more delays
USDA doesn’t know when facility will be able to handle the most dangerous pathogens
A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it
An experimental Alzheimer’s compound prevented damaging protein clumps from forming in the brains of mice, helping nerve cells survive longer and reducing amyloid buildup. The treatment also appeared to improve heart health and slow some signs of aging, raising hopes for an entirely new way to combat dementia.
This 10-cent heart drug cuts hospitalizations by 25%
A centuries-old heart drug costing less than ten cents a day could help keep heart-failure patients out of the hospital. New research suggests low-dose digoxin can reduce heart-failure hospitalizations by about 25%, potentially paving the way for its return as a major treatment.